IP Library › Granted Patent US 10,294,458
Granted Patent B2
US 10,294,458 · App. 15/240,190 · Granted May 21, 2019

Methods of differentiating stem cells by modulating miR-124

Inventors: Jau-Nan Lee (Kaohsiung, TW); Tony Tung-Yin Lee (Yakima, WA); Yuta Lee (Kaohsiung, TW)
Assignee: ACCELERATED BIOSCIENCES CORP.
C12N5/0678A61K35/39C12N5/0605C12P19/34C12P21/02G01N33/507G01N33/5023G01N33/5073C12N2501/115C12N2501/65C12N2506/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,294,458
App. No.
15/240,190
Granted
May 21, 2019
Kind
B2
Abstract

Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.

Claims (8)

1. An isolated pancreatic progenitor cell, wherein the isolated pancreatic progenitor cell expresses insulin and betatrophin.

2. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell further expresses C-peptide.

3. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell further expresses Ngn3.

4. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell is differentiated from a human trophoblast stem cell.

5. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell is differentiated from a trophoblast stem cell, and wherein the isolated pancreatic progenitor cell has a normal karyotype compared to the trophoblast stem cell.

6. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell is differentiated from a trophoblast stem cell, and wherein the isolated pancreatic progenitor cell has low or absence of CD133 expression compared to the trophoblast stem cell.

7. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell is differentiated from a trophoblast stem cell, and wherein the isolated pancreatic progenitor cell has low or absence of CD133 expression compared to the trophoblast stem cell.

8. The isolated pancreatic progenitor cell of claim 1 , wherein the isolated pancreatic progenitor cell further expresses C-peptide and Ngn3.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 7, 2017
From: ACCELERATED BIOSCIENCES CORP.
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 043279/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: LEE, JAU-NAN; LEE, TONY TUNG-YIN; LEE, YUTA
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 040670/0687 →
Continuity (4)
Division 14090804 · Nov 26, 2013
Provisional Application 61877156 · Sep 12, 2013
Provisional Application 61732162 · Nov 30, 2012
Related Publication 20170067024A1 · Mar 9, 2017